Navigation Links
New vaccine helps allergy and asthma patients

Allergy and asthma patients can now breathe easy. Literally. A new vaccine called grass pollen vaccine has been shown to be effective in improving the quality of life and has also reduced medication requirements in these patients. These and other findings of this study are reported in the latest issue of the Journal of Allergy and Clinical Immunology

Samantha M. Walker, PhD, of the Imperial College School of Medicine at the National Heart and Lung Institute in London, and colleagues in the United Kingdom and Italy observed that the vaccine when given weekly for four weeks and later monthly for two years dramatically reduced the breathlessness and medication requirements of these long suffering hapless patients.

These researchers studied two groups of patients. One was the immunotherapy group who received the injections the other group was the placebo group which received placebo injection whenever the other group received the vaccine. When compared after the two-year period the difference was startling.

While the symptoms came down by 49% in the group, which received the grass pollen vaccine, the medication requirements came down by 80% and the asthmatic chest symptoms like coughing and breathing difficulties came down by 90%.

For patients who have been suffering chronically with no clear-cut cure in sight this study has opened a lot of new options to get on with life. By helping in reducing both symptoms and the treatment aspects this wonder vaccine has come to stay as the, “ in thing” for asthmatics. Lets breathe easy!!
'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
5. HIV did not arise from polio vaccine
6. Double impact vaccine
7. High Demand for a child vaccine
8. A new vaccine for leukemia
9. Shortage of MMR vaccine
10. Anthrax vaccine produced
11. Problematic Use of smallpox vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: